Introduction
Theu se of covalent protein ligands for interrogating protein function has proven extremely helpful in chemical biology.H owever,t ranslation of probes into covalent drugs was abolished from drug discovery programs for along time, mainly due to concerns regarding their idiosyncratic toxicity.I nr ecent years, however, the development of covalent inhibitors has received ar enewed attention, influenced by an exponentially increasing literature of successful examples, [1] ab etter understanding of mechanisms of action, [2] refined compound selectivity, [3] and several drug approvals (e.g., telaprevir, carfilzomib, ibrutinib,o simertinib,n eratinib,a nd afatinib;Scheme 1).
Most covalent ligands contain an affinity motif that enables selective binding to ap rotein active site and, in turn, directs the reactive warhead towards an ucleophilic residue of the target protein. Ideally,t his facilitates formation of ac ovalent, irreversible bond with just the intended functional group among thousands of nucleophiles in the proteome. While ar ange of covalent ligands has been developed to target adiverse array of proteins,most of them were designed to target an accessible,s uitably located nucleophilic cysteine residue in the protein pocket. Theu nique reactivity of cysteine allows for acrylamides to be the electrophilic functionalities of choice in these cases.T hese soft electrophiles require proximity to the nucleophilic,targeted cysteine to react, thus minimizing off-target labeling.I tis often the case that the protein of interest lacks ac ysteiner esidue amenable to modification, since cysteines are only found in 1.5 %ofprotein pockets. [4] Exploiting less nucleophilic residues for covalent labeling in protein binding sites has been less common, but there is ar apidly increasing number of examples of compounds capable of selective covalent targeting of tyrosine, [5] lysine, [6] serine, [7] threonine, [8] as well as glutamic acid [9] residues in the context of activity-based proteome profiling (ABPP) probes or covalent inhibitors.T he development of irreversibly binding probes and inhibitors that rely on covalent modification of Ty r, Lyso rS er residues generally requires compounds bearing considerably reactive electrophilic warheads that can form ac ovalent bond with the targeted residue.A dditionally,t he surrounding protein environment enhances the Selective covalent modification of atargeted protein is apowerful tool in chemical biology and drug discovery, with applications ranging from identification and characterization of proteins and their functions to the development of targeted covalent inhibitors.Most covalent ligands contain an affinity motif and an electrophilic warhead that reacts with anucleophilic residue of the targeted protein. Because the electrophilic warhead is prone to react and modify off-target nucleophiles,i ts reactivity should be balanced carefully to maximizetarget selectivity.A rylfluorosulfates have recently emerged as latent electrophiles for selective labeling of context-specific tyrosine and lysine residues in protein pockets.H ere,wer eview the recent but intense introduction of arylfluorosulfates into the arsenal of available warheads for selective covalent modification of proteins.W ehighlight the untapped potential of this functional group for use in chemical biology and drug discovery. nucleophilicity of the targeted residues by perturbing the pK a values of their side chains.For example,the e-amino groups of lysine residues display an intrinsic pK a of 10.4, and are most likely positively charged and unavailable for covalent modification under physiological conditions. [10] However,a na dequate protein environment that effectively buries aparticular lysine and/or surrounds it with the appropriate residues can contribute to depress the pK a of its e-amino group down to five units,making it readily available as an ucleophile. [11] Careful selection and optimization of warhead reactivity is essential to maximize target selectivity and minimize the modification of unwanted endogenous nucleophiles.Sulfonyl fluoride-based warheads have been extensively used for the chemical biology community for covalent modification of ar ange of proteins,a nd this subject has been excellently reviewed in detail by Narayanan and Jones. [12] Sulfonyl fluorides have been shown to bind covalently to Ty r, Lys and Ser amino acids in protein binding sites,b ut also to Thr, Cys,a nd His residues (Scheme 2a). [12, 13] Sulfonyl fluoridecontaining ligands have ab alanced reactivity and modest aqueous stability and are incredibly useful tools in chemical biology,particularly explored as ABPP probes.However,the relatively high reactivity and promiscuity of sulfonyl fluoridebased warheads may jeopardize the efficiencyofthese probes in whole-cell investigations or experiments that require extended incubation times,w hich is an important limitation for the development of covalent inhibitors in drug discovery campaigns.
Am uch more stable and closely related sulfur(VI)-fluoride group,t he arylfluorosulfates (Scheme 2b), has recently emerged as an alternative warhead for covalent modifications of context specific Ty ra nd Lys, but also Ser residues in protein binding sites that comprise an appropriate protein microenvironment for the sulfur(VI)-fluoride exchange (SuFEx) reaction to occur. [14] In this Minireview we highlight the unique properties of fluorosulfate-based warheads in the context of other options, provide examples of covalent protein modification by fluorosulfate-derived probes,and discuss their potential in probe and covalent inhibitor development for drug discovery and general chemical biology investigations.
Reactivity of Arylfluorosulfate-Based Warheads
Sulfonyl fluoride-derived warheads were broadly popularized in the 1960s as covalent protein modifiers after early reports describing their mechanism of action. [15] Irreversible protein binders containing sulfonyl fluorides that take advantage of their relatively low reactivity for selective covalent inhibition of ar ange of proteins have been continuously developed since then. [12] On the other hand, despite arylfluorosulfates being first reported in the 1930s, [16] the lack of robust synthetic methods for their preparation resulted in only af ew reports entertaining this functional group,a nd it was not adapted as warhead for covalent modification of proteins until 2015 by Kelly and co-workers. [17] Ther esurgence of arylfluorosulfates was pioneered by the Sharpless group due to development of afacile method for the synthesis of these compounds (Scheme 2b).
[14a] Simply incubating phenols with sulfuryl fluoride (gas) and base selectively provides their corresponding arylfluorosulfate derivatives even in the presence of amines,c arboxylates,a nd aliphatic alcohols.M oreover,t wo bench-stable "F-SO 2 + "d onor reagents have subsequently been reported for arylfluorosulfate syntheses (AISF and FDIT,S cheme 2), thus overcoming the inconvenient handling of sulfuryl fluoride. [18] In this regard, another practical transformation of phenols to arylfluorosulfates was also developed by ex situ generation of SO 2 F 2 by means of atwo-chamber reactor. [19] Pablo Martín-Gago is currently an assistant professor at Copenhagen University. 
Unlike sulfonyl fluorides,a rylfluorosulfates have proved to display remarkable stability towards hydrolysis and nucleophiles in general, since they remain intact in phosphate buffer (pH 10) for up to two weeks and in neutral buffers for months.Inaddition, arylfluorosulfates have been shown to be virtually unreactive in the presence of amino acids or natural products containing an array of different functional groups. [14a, 20] In the context of covalent protein modification, this superior stability of arylfluorosulfates compared to sulfonyl fluorides should lead to an even more selective protein labeling and minimized off-target modification. Granted that the ligand-binding motif provides sufficient residence time projecting the warhead towards the targeted residue,l atent arylfluorosulfate electrophiles have been shown to exclusively react upon activation in particular binding sites.T hus,t he surrounding protein environment requires basic residues (Arg,L ys,o rH is) that decrease the pK a of the targeted nucleophilic residue and/or that facilitate fluoride ion departure (e.g.b yh ydrogen bonding interactions) to achieve the SuFEx reaction. [21] 
Arylfluorosulfate-Based Targeted Covalent Inhibitors
In the first reported attempt to use fluorosulfates for covalent protein modification, Kelly and co-workers replaced the sulfonyl fluoride-based warhead in previously reported fluorogenic transthyretin (TTR) probes [22] with an ArOSO 2 F group (Scheme 3a). [17] Unlike the sulfonyl fluoride-containing probes 1 and 2,a rylfluorosulfates 3 and 4 reacted slowly with the targeted pK a -perturbed Lys15 e-amino group of transthyretin and did not reach full conversion, due to their lower reactivity.T he additional oxygen atom present in the fluorosulfate-based warhead could also contribute to the inefficient covalent binding,b yd ecreasing the proximity of the fluorosulfate sulfur atom to the nucleophilic Lys15 side chain or by geometrically compromising the hydrogen bondmediated stabilization of the leaving fluorine atom by neighboring residues.I na ddition, probes 3 and 4 proved to be essentially unreactive towards the whole proteome.
Interestingly,a dducts of TTR with probe 3 or 4 were not detected after more than 8h incubation time.O nly SO 3 À -modified TTR, the corresponding hydrolysis product (Scheme 3b), was observed by mass spectrometry.T his proteinmediated hydrolysis of the ArOSO 2 -covalent adducts appears to be intrinsic to TTR, since hydrolysis of aT TR-16 (Scheme 5b)c onjugate with formal transfer of SO 3 À to Lys15 was also observed over several days. [23] Thep ropensity and potential applicability of arylfluorosulfates for irreversible protein Lyss ulfamation and/or Tyr sulfation remains to be explored in further detail. In asimilar approach, attempting to overcome the limited stability of as ulfonyl fluoride-based covalent ligand of the mRNA decapping scavenger enzyme (DcpS), [24] Jones and co-workers incorporated an arylfluorosulfate electrophile (6)into the previously developed DcpS covalent inhibitor 5 (Scheme 4). [25] Remarkably,while the sulfonyl fluoride probe 5 was designed and proved to covalently label Ty r143 in the binding pocket of DcpS (Figure 1a) , fluorosulfate 6 covalently labeled Dcps at the non-catalytic Ser272 (Figure 1b) . Thef ormation of the covalent adduct was shown by intact mass LC-MS and native electrospray ionization (ESI) MS analysis,w hich also revealed the presence of Ser272 dehydrated DcpS,t hat occurs via b-elimination of the fluorosulfate-DcpS conjugate (Scheme 4). Formation of Dha272-DcpS upon covalent arylfluorosulfate binding takes place rapidly under acidic LC-MS conditions,b ut slowly at pH 7.4, as shown by native ESI-MS.I nsights into the general dehydration tendency of Ser-a nd Thr-modified residues in protein binding sites using ArOSO 2 F-based warheads would be While the shorter sulfonyl fluoride warhead of 5 was optimally accommodated towards the Ty r143 side chain (Figure 1a) , the additional bridging oxygen atom of the arylfluorosulfate warhead in compound 6 results in improved positioning of the electrophilic sulfur(IV) atom towards Ser272 (Figure 1b) .
This non-catalytic serine is neighbored by two basic amino acids (Lys142 and Arg294) and located close to three histidine residues (His268, 277, and 279). This assortment of basic side chains likely contributes to the SuFEx reaction by lowering the pK a of the hydroxyl side chain of Ser272 and/or helping the departure of the fluoride atom. Interestingly,w hile the para-isomer 5 labels Ty r143 in the DcpS binding pocket, the ortho-a nd meta-regioisomers 7 and 8 (Scheme 4) were predicted to locate their electrophilic warheads differently and indeed proved to react with the proximate Ty r113 phenol side chain instead. [24] Investigation of the corresponding ortho-a nd meta-arylfluorosulfate derivatives would provide further insights into their preferential positioning and reactivity.I tw ould also provide valuable information for future attempts to design more stable and selective arylfluorosulfate-based covalent inhibitors based on known sulfonyl fluoride-derived compounds.D espite the similarity of both sulfur(VI)-fluoride groups,t he length and geometry of their warheads differ due to the additional oxygen atom present in the fluorosulfate moiety,a nd we predict that optimization may be required on ac ase-by-case basis.F urther characterization of the stability of these compounds revealed that 6 remained intact for up to 24 hi nP BS (pH 7.4), while the analogous sulfonyl fluoride 5 was largely hydrolyzed under the same experimental conditions.F or ac omparable measurement of non-specific covalent protein labeling, 5 and 6 were incubated with human serum albumin (HSA), and the reactions were followed by LC-MS.While 5-HSA and 5( 2)-HSA covalent adducts formed after 24 hincubation, covalent labeling with 6 was not detected, as ar esult of the superior kinetic stability and minimal promiscuity of arylfluorosulfatebased warheads.
In order to sort out the plausible use of arylfluorosulfatebased warheads in drug discovery,wewent astep further and provided metabolic stability and membrane permeability data of both 6 and DAQ1 (Scheme 4), an analogous inhibitor lacking the -OSO 2 Ff unctionality.I nterestingly, 6 showed areduced metabolic turnover rate in human liver microsomes. Arylfluorosulfate 6 was shown to migrate slower than DAQ1, but still displayed acceptable membrane permeability,a lthough the enhanced apparent permeability from the BtoA side suggests that efflux is occurring,abehavior not observed for DAQ1.The collection of more ADME data from potential arylflurosulfate-based covalent inhibitors and their analogs lacking the corresponding electrophile will be important to gain insights into the potential use of fluorosulfate warheads in drug discovery research.
Reactivity and Selectivity of Simple Arylfluorosulfate Probes Towards the Human Proteome
Due to their lower reactivity,a rylfluorosulfate probes provide am ore selective covalent labeling of proteins than the extensively used aryl sulfonyl fluorides in whole human proteome experiments. [17] TheK elly and Sharpless groups compared the proteome reactivity of both functional groups and showed that structurally simple arylfluorosulfate-containing probes 9 and 11 (Scheme 5a)c ovalently modified al ow number of proteins in HeLa cell culture and lysate, while the analogous aryl sulfonyl fluoride probe 10 (Scheme 5a)l abeled aw ide array of proteins under the same conditions. [21] SDS-PAGEs eparation of proteins from HeLa cells treated with 9 revealed that this probe selectively binds several members of the proteome in the 15 kDa range.Stable isotope labeling by amino acids in cell culture (SILAC) [26] experiments were performed to identify these 15 kDa targets to be the fatty acid binding proteins 3a nd 5( FABP3 and FABP5) and the cellular retinoic acid binding protein 2 (CRABP2), which are members of the intracellular lipid binding protein (iLPB) family. [27] Complete covalent adduct formation was observed upon incubation of recombinant CRABP2 (2 mm)and 9 (100 mm)after 48 h, and 80 %covalent labeling of recombinant FABP5 was achieved under the same experimental conditions.I na ddition, recombinant human FABP4, as tructurally similar iLBP,f ormed 90 %c ovalent adduct with 9 as seen by LC-MS analysis.However,covalent binding of this probe to FABP3 could not be validated in this or other attempted experiments.I no rder to accelerate covalent bond formation by enhancing the potencyo ft he affinity motif,b iphenyl-containing probes 12 and 13 (Scheme 5) were synthesized and yielded quantitative covalent adduct formation with recombinant CRABP2 within 1h. Probes 12 and 13 (100 mm)s howed ar emarkable and unexpected selectivity for CRABP2, since labeling of FABP3, FABP4, and FABP5 (2 mm)w as not detected, even at 24 h incubation times.S elective and nearly complete covalent labeling of overexpressed GFP-CRABP2 was achieved with the more cell-permeable probe 12 (20 mm)inliving HEK293T cells overexpressing both GFP-CRABP2 and FABP5-GFP. iLBPs contain an arylfluorosulfate-desirable conserved Arg-Tyr-Arg motif in their binding pocket (Figure 2 ). [27] Tandem mass spectrometry experiments [28] revealed that arylfluorosulfate probes bind iLBPs via ac onserved Tyr residue in their fatty acid-binding sites.T he Arg duo perturb the pK a of the Ty rp henol side chain and/or stabilize the departing fluoride during the sulfur(VI)-fluoride exchange reaction. Incubation of 13 and recombinant CRABP2 in buffers ranging from pH 4.9 to 10.4 revealed that 13 labels CRABP2 in ap H-dependent manner (labeling efficiency increases with pH value), and that the phenol side chain of Ty r134 displays an apparent pK a of 7.6, indicating pK a perturbation of the phenol by Arg111 and/or Arg132. To gain insight into the role of the Arg pair in covalent bond formation, CRABP2 mutants Arg111Leu and Arg132Leu were incubated with 13 at different pHs.Both point mutations resulted in am arkedly decreased covalent labeling even at pH 10.4, which is higher than the pK a of standard Ty rs ide chains,s uggesting that the neighboring arginines are directly involved in catalyzing the SuFEx reaction.
Ac rystal structure resulting from probe 12 in complex with CRABP2 unambiguously proved the formation of ad iarylsulfate diester bond between ligand and Ty r134 and showed that the biaryl group engaged in hydrophobic interactions with several residues in the retinoic acid (RA) binding site (Figure 2) . [29] Thec rystal structure revealed that the Thr75-Gly78 b-turn in CRABP2 provides further space to accommodate the outer ring of 12 than other iLBPs,w hich explains the significant CRABP2 selectivity of the biphenylbased probes. [21] In addition, 12-mediated irreversible inactivation of CRABP2 decreased the transcriptional activation of retinoic acid receptor alpha (RARa), which regulates transcription in al igand-dependent manner, [30] by inhibiting retinoic acid delivery. 
Inverse Drug Discovery Using Arylfluorosulfate Probes
With the knowledge that simple arylfluorosulfates display aproteome preference for iLBPs,t he Sharpless,W ilson, and Kelly groups ventured into using more structurally complex arylfluorosulfate electrophile probes in an inverse drug discovery approach. [23] In this strategy,asmall number of arylfluorosulfate clickable probes with intermediate structural complexity was exposed to the human proteome and selectively labeled protein targets were identified and validated by means of mutagenesis experiments,mass spectrometry analysis,a nd X-ray crystallography.T hree different arylfluorosulfate probes were selected, which contained different aryl motifs,f unctional groups,a sw ell as H-bond donors and acceptors.T hese chemical features endow the probes with sufficient reversible binding energy to preferentially bind particular groups of proteins,and together with the narrow reactivity of the arylfluorosulfate electrophile,should result in ah ighly selective covalent labeling of different proteome members.
Living HEK293T cells and lysates were treated with alkyne containing probes 14, 15,a nd 16 alone or in the presence of an excess of competitor (14 c, 15 c,o r16 c, respectively) previous to copper(I)-catalyzed azide-alkyne cycloaddition (CuAAC) click reaction [31] with either tetramethylrhodamine-or diazo biotin-azide.L abeled proteins were then investigated by fluorescence SDS-PAGEortandem mass spectrometry after streptavidin enrichment, trypsin digestion and six-plex tandem mass tags (TMTs) labeling. [32] Disappearance of fluorescence signal (in SDS-PAGE) or abundance (in MS-MS) of covalently modified proteins by the alkyne probes in the presence of the corresponding competitors indicate ah igh extent of covalent protein labeling. Therefore,e nabling differentiation between complete irreversible binding of low-abundance proteins and partial modification of proteins present in higher concentrations. [33] Covalently targeted proteome members by each probe were identified by quantitative proteomics and rated on the basis of ahigh competition ratio (relative abundance of acorresponding protein in an experiment where only alkyne probe vs. alkyne probe plus competitor was applied) and low p-values. Based on that ranking, 12 different proteins,f rom which structural information was already available in the Protein Data Bank, were selected for further validation studies.Only in one case,d id LC-ESI-MS demonstrate that the corresponding recombinant protein did not react upon incubation with the arylfluorosulfate compound, while the recombinant proteins of the remaining 11 selected targets proved to be covalently labeled by their respective probes under the experimental conditions. Interestingly,adiverse set of proteins was enriched by different probes,m arking the predicted importance of the peculiarly distinct binding motifs to achieve selective labeling. Afew protein targets were,however,shown to react also with different probes.G lutathione S-transferase p (GSTP1) was found to be enriched in the volcano plots of both 14 and 15, and tethering experiments corroborated adduct formation in both cases by LC-ESI-MS.M utagenesis experiments of the two potential labeled Ty rr esidues [13c, 34] one at at ime (Y7F and Y108F) or both at the same time (Y7F,T108F) revealed that 15 reacts preferentially with Ty r7, but Ty r108 can be labeled as well, since removal of both nucleophiles inside the GSTP1 binding site is necessary to completely abrogate covalent labeling as shown by in-gel fluorescence.T he importance of the neighboring basic Arg13 residue was corroborated by showing that an R13K mutant retained fluorosulfate reactivity,w hile an R13Q mutation abolished covalent adduct formation.
Them ultidimensional protein identification technology (MuDPIT) LC-MS/MS competition ratio experiment identified another glutathione S-transferase,G STO1, as target of 14.W ec orroborated quantitative covalent adduct formation over 48 hwith recombinant enzyme and aco-crystal structure proved sulfate diester bond formation to Tyr229 (Figure 3b) .
Mutagenesis experiments highlighted the importance of both proximal Lys57 and Lys59 for labeling (Figure 3) , since K57Q and K59Q mutations attenuated covalent adduct formation. However,c ovalent labeling of these mutants was rescued at pH 10.5, suggesting that the main role of the surrounding Lys residues is to lower the pK a of the Ty r229 phenol in order to promote SuFEx reaction.
Efforts directed to validate nucleoside diphosphate kinase A( NME1) as at arget of 15 led to several interesting findings.LC-ESI-MS corroborated complete formation of the NME1-15 c covalent adduct, which the authors managed to crystallize.T he resulting X-ray crystal structure revealed asulfamate-mediated covalent bond to the Lys12 side chain, providing the first example of an X-ray crystal structure showing af luorosulfate warhead labeling al ysine residue (Figure 4 ). This is particularly interesting, because an earby Ty r52 is also available for covalent bond formation. However, only the side chain of Lys12, which is surrounded by basic Arg105 and His118 residues and predicted to be intrinsically nucleophilic, [35] proved to partake in covalent adduct formation, since aMNE1-K12A mutant failed to react with 15.
Theremaining eight selected proteins (BLVRA, TIGAR, HSDL2, ALKBH5, TMPT,H MOX2, CRABP2, and TTR) were also validated by measuring covalent adduct formation by LC-ESI-MS and, in some cases,t he labeling site was assigned by tandem mass spectrometry (MS-MS) analysis. Interestingly, 15 was found to react with thiopurine Smethyltransferase (TPMT) by binding to the solvent exposed Lys32 nearby the active site.H owever,c ovalent labeling of FTO,w hich was identified in the competition ratio experiment with probe 14,w as not observed and failed to be validated under various experimental conditions.A sp ointed out, this could be explained by differences between the recombinant and the endogenous protein in acellular context, as post-translational modification of FTOo rf ormation of ap rotein complex could be necessary for covalent modification to occur. [23] In vitro functional assays demonstrated ad ecreased GSTP1 and BLVRA enzymatic activity as ar esult of treatment with 14 and/or 15 probes.Inaddition, known inhibitors or endogenous ligands compete with the fluorosulfate-based probes for the protein binding sites of NME1, CRABP2, and TTR. [36] Particularly interesting is the fact that covalent probe 14 is the first reported small molecule probe of hydroxysteroid dehydrogenase-like protein 2( HSDL2). [37] Several of these proteins possess ah igh interest for drug discovery and these encouraging results indicate that optimization of the compounds used here could provide potential covalent drug candidates for the treatment of ad iverse range of diseases.
Summary and Outlook
Ther ecent development of af acile method for the synthesis of arylfluorosulfates has spurred the use of this latent electrophile for covalent protein modification. Thelow and narrow intrinsic reactivity of fluorosulfate-based warheads assures minimal covalent labeling of off-target nucleophiles in acellular context, making these compounds largely unreactive towards the human proteome unless rigorous conditions are met (e.g.t he presence of basic residues that decrease the pK a of the targeted nucleophilic residue and/or facilitate the departure of the fluoride ion).
Similar to the reports discussed herein, several recent examples provide additional encouraging data to start considering the use of arylfluorosulfate-targeted covalent inhibitors in drug discovery.T hus,proteins containing genetically encoded fluorosulfate-l-tyrosine (FSY) have been shown to react with strategically located proximal Ty r, Lys, and His residues on the surfaces of their interacting protein partners in live E. coli,a nd exhibited no toxicity towards E. coli or mammalian cells at concentrations up to 1mm. [38] These results approved the use of genetically encoded FSY for covalent attachment of protein partners in vivo and suggest the value of arylfluorosulfate-based compounds for the selective covalent labeling of Ty r, Lys, or His residues on protein surfaces for targeting specific protein-protein interactions.I na ddition, reactive covalent docking experiments have already proved useful to predict possible covalent binding sites of arylfluorosulfate probes. [23] This suggests that rational targeting of intrinsically reactive Ty r, Lysoreven Ser and His residues could be applied in drug discovery for agiven protein of interest that displays afluorosulfate-desired protein microenvironment, especially with ah igh-affinity, reversible ligand in hand that can be modified. Furthermore, aplatform for late-stage compound functionalization has also been developed, that allows for the in situ, selective arylfluorosulfate formation from phenol-containing compounds in a9 6-well plate format, allowing the generation of arylfluorosulfate compound libraries that can be directly applied in cell-based or enzymatic assays. [39] To date,a rylfluorosulfate-based probes have been found to modify protein pockets preferentially through tyrosine residues (in iLBPs,G STP1, GSTO1, BLVRA, HMOX2, HSDL2, ALKBH5, and TIGAR proteins) and lysine residues (in TTR, NME1, TMPT,a nd HMOX2) but also serine in DcpS.W ep redict that the number of examples of arylfluorosulfate-derived covalent ligands will substantially increase over the coming years,w hich should provide further insights into the structure and substituent effects on reactivity, chemical and metabolic stability,a sw ell as covalent target engagement selectivity of these compounds.W eanticipate to witness the application of other "SuFEx-able" warheads (e.g., alkyl or aryliminosulfur oxy(di or mono)fluorides) [40] in chemical biology research, which could lead to the development of targeted covalent inhibitors with even lower proteome-wide reactivity and different amino acid labeling preference.
These are encouraging times for the field of covalent protein modification, and yet the powerful addition of arylfluorosulfates to the catalogue of available warheads promises even more exciting developments in the fields of covalent probes and inhibitors in chemical biology and drug discovery.
